LEADER 01060nam0-2200337---450- 001 990009446540403321 005 20111010131621.0 010 $a0904498204 035 $a000944654 035 $aFED01000944654 035 $a(Aleph)000944654FED01 035 $a000944654 100 $a20111010d1987----km-y0itay50------ba 101 0 $aeng 102 $aGB 105 $aa-------101yy 200 1 $aMolecular pathology$eBiochemical Society symposium no. 53 held at University College London, December 1985$forganized and edited by J. Kay and M.J. Morgan 210 $aLondon$cBiochemical Society$d1987 215 $aXIV, 182 p.$cill.$d26 cm 225 1 $aBiochemical society symposia$v53 610 0 $aPatologia molecolare 702 1$aKay,$bJohn 702 1$aMorgan,$bM. J. 710 12$aBiochemical society symposium,$d53.$f<1986 ;$eLondon>$0513296 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990009446540403321 952 $a47 D 23$b1447$fDMVAP 959 $aDMVAP 996 $aMolecular pathology$9760635 997 $aUNINA LEADER 00953nam0-22003491i-450 001 990003338010403321 005 20230426100728.0 010 $a2-13-044755-4 035 $a000333801 035 $aFED01000333801 035 $a(Aleph)000333801FED01 035 $a000333801 100 $a20001010d1992----km-y0itay50------ba 101 0 $afre 102 $aFR 105 $ay-------001yy 200 1 $a<>systéme fiscal francais$fLucien Mehl, Pierre Beltrame 205 $a5. ed 210 $aParis$cPresses Universitaires de France$d1992 215 $a127 p.$d18 cm 610 0 $aDiritto tributario$aFrancia 676 $a343.04 700 1$aMehl,$bLucien$0112398 701 1$aBeltrame,$bPierre$0280830 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990003338010403321 952 $a332 MEH$bLINGUE 2447$fDECLI 959 $aDECLI 996 $aSystéme fiscal francais$92870204 997 $aUNINA DB $aING01 LEADER 01314nam 2200373 a 450 001 9910701971803321 005 20120711072001.0 035 $a(CKB)5470000002422398 035 $a(OCoLC)798803122 035 $a(EXLCZ)995470000002422398 100 $a20120711d2012 ua 0 101 0 $aeng 135 $aurmn||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aPrescription drugs$b[electronic resource] $eFDA has met most performance goals for reviewing applications : report to congressional requesters 210 1$a[Washington, D.C.] :$cU.S. Govt. Accountability Office,$d[2012] 215 $a1 online resource (iii, 46 pages) $cillustrations 300 $aTitle from PDF title screen (viewed July 10, 2012). 300 $a"March 2012." 300 $a"GAO-12-500." 320 $aIncludes bibliographical references. 517 $aPrescription drugs 606 $aDrug approval$xEconomic aspects$zUnited States 606 $aPharmaceutical industry$xEconomic aspects$zUnited States 615 0$aDrug approval$xEconomic aspects 615 0$aPharmaceutical industry$xEconomic aspects 801 0$bGPO 801 1$bGPO 906 $aBOOK 912 $a9910701971803321 996 $aPrescription drugs$92884258 997 $aUNINA